Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OKUR compared with AVR: revenue, margins and what each company keeps, and the suppliers and customers both name
OKUR
OnKure Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AVR
Anteris Technologies Global Corp.
Change
Mkt cap
Revenue
Revenue
vs
Compare
OKUR
OnKure Therapeutics, Inc.
vs
AVR
Anteris Technologies Global Corp.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
OKUR: latest quarter not drawable. AVR: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OKUR, solid
AVR, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OKUR
2
—
PharmaBlock Sciences (Nanjing)
unlisted
supplier
—
STA Pharmaceutical Hong Kong
unlisted
supplier
Shared
0
No shared counterparties.
Only AVR
2
—
4C
unlisted
customer
—
LeMaitre Vascular
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
OKUR
OnKure Therapeutics, Inc.
Change
2.63
▲
+0.50%
· post 2.63
Mkt cap
$106.1M
Revenue
—
Revenue
—
AVR
Anteris Technologies Global Corp.
Change
6.30
▼
−1.81%
· post 6.30
Closed
Oct 30 '26
Mkt cap
$615.0M
Revenue
$1M
Q2 FY26
Revenue
$2M
FY25
vs
Compare
Closed
Oct 30 '26
OKUR
OnKure Therapeutics, Inc.
vs
AVR
Anteris Technologies Global Corp.
2.63
▲
+0.50%
post 2.63
Price
6.30
▼
−1.81%
post 6.30
$106.1M
Mkt cap
$615.0M
—
Revenue
$1M
Q2 FY26
—
Revenue
$2M
FY25
Change
Change
OKUR
2.63
▲
+0.50%
vs
AVR
6.30
▼
−1.81%
Closed
Oct 30 '26